APX Platform & Revelle Aesthetics Enter Unique Strategic Partnership Focused on Growing Demand for Body Rejuvenation

September 23, 2022
APX

APX Platform, the aesthetic industry’s premier business intelligence, employee education, training, financial and data analytics platform, and Revelle Aesthetics, Inc, makers of the Avéli cellulite device, are joining forces to provide concierge-level practice development and economic support to aesthetic practices as they increase their focus on the rapidly growing demand for body contouring solutions, including effective treatments of cellulite.

The aesthetics market continues to see double-digit growth, driven largely by the rise in body contouring treatment options. As a result, many aesthetics practices are shifting their focus to best serve this growing consumer need.

Companies like APX Platform and Revelle Aesthetics, Inc., have taken a more forward thinking and practice-centric approach to the aesthetics market, focusing less on promoting specific modalities or company offerings, and more on helping aesthetics providers develop their own internal practice efficiencies and infrastructure to build sustainable practice growth and profitability.

“This partnership was incubated out of identifying real gaps in the industry,” said Terri Ross, Founder and Co-CEO of APX Platform. “After decades of consulting with hundreds of aesthetic practices, we have seen providers purchase new devices or technology without really being fully educated on how best to integrate them or maximize their investment potential. That’s where APX Platform comes in. Everyone from the front desk team to the providers are trained on how to explain the features and benefits of the newly adopted treatments, convert patients in the consultation process, combine them with other procedures, and analyze their data to track profitability.”

Read more at APX Platform >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Acquisition Lets AI and Operators Learn From Nearly $2 Billion in Annual Aesthetics Transactions
    • Galderma Celebrates 30 Years of Restylane
    • FDA Issues Letter to Evolus Over Jeuveau Social Media Promotion
    • North Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Retatrutide Phase 3 Trial: Adults With Type 2 Diabetes Lost Average of 50 Pounds